
Dave Trong Nguyen
Supervisory Patent Examiner (ID: 2395, Phone: (571)272-0731 , Office: P/1634 )
| Most Active Art Unit | 1633 |
| Art Unit(s) | 1633, 1804, 1621, 1634, 1632 |
| Total Applications | 624 |
| Issued Applications | 320 |
| Pending Applications | 143 |
| Abandoned Applications | 162 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 1533815
[patent_doc_number] => 06410721
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-06-25
[patent_title] => 'Polynucleotide decoys that inhibit MHC-II expression and uses thereof'
[patent_app_type] => B1
[patent_app_number] => 09/225645
[patent_app_country] => US
[patent_app_date] => 1999-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 9
[patent_no_of_words] => 13351
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/410/06410721.pdf
[firstpage_image] =>[orig_patent_app_number] => 09225645
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/225645 | Polynucleotide decoys that inhibit MHC-II expression and uses thereof | Jan 4, 1999 | Issued |
Array
(
[id] => 4320139
[patent_doc_number] => 06328957
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-12-11
[patent_title] => 'Heat shock proteins and the treatment of tumors'
[patent_app_type] => 1
[patent_app_number] => 9/225234
[patent_app_country] => US
[patent_app_date] => 1999-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 10
[patent_no_of_words] => 5165
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/328/06328957.pdf
[firstpage_image] =>[orig_patent_app_number] => 225234
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/225234 | Heat shock proteins and the treatment of tumors | Jan 3, 1999 | Issued |
Array
(
[id] => 4324130
[patent_doc_number] => 06312682
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-11-06
[patent_title] => 'Retroviral vectors'
[patent_app_type] => 1
[patent_app_number] => 9/224014
[patent_app_country] => US
[patent_app_date] => 1998-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 5864
[patent_no_of_claims] => 71
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/312/06312682.pdf
[firstpage_image] =>[orig_patent_app_number] => 224014
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/224014 | Retroviral vectors | Dec 27, 1998 | Issued |
Array
(
[id] => 1507096
[patent_doc_number] => 06440726
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-08-27
[patent_title] => 'Expression vectors comprising multiple shear stress responsive elements (SSRE) and methods of use for treating disorders related to vasculogenesis and/or angiogenesis in a shear stress environment'
[patent_app_type] => B1
[patent_app_number] => 09/220510
[patent_app_country] => US
[patent_app_date] => 1998-12-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 16079
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/440/06440726.pdf
[firstpage_image] =>[orig_patent_app_number] => 09220510
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/220510 | Expression vectors comprising multiple shear stress responsive elements (SSRE) and methods of use for treating disorders related to vasculogenesis and/or angiogenesis in a shear stress environment | Dec 23, 1998 | Issued |
Array
(
[id] => 5889071
[patent_doc_number] => 20020013283
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-01-31
[patent_title] => 'METHOD AND ARTICLES FOR TRANSFECTION OF GENETIC MATERIAL'
[patent_app_type] => new
[patent_app_number] => 09/219907
[patent_app_country] => US
[patent_app_date] => 1998-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4583
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0013/20020013283.pdf
[firstpage_image] =>[orig_patent_app_number] => 09219907
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/219907 | Method and articles for transfection of genetic material | Dec 22, 1998 | Issued |
Array
(
[id] => 1474230
[patent_doc_number] => 06387695
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-05-14
[patent_title] => 'DNA pharmaceutical formulations comprising citrate or triethanolamine and combinations thereof'
[patent_app_type] => B1
[patent_app_number] => 09/218590
[patent_app_country] => US
[patent_app_date] => 1998-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7158
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/387/06387695.pdf
[firstpage_image] =>[orig_patent_app_number] => 09218590
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/218590 | DNA pharmaceutical formulations comprising citrate or triethanolamine and combinations thereof | Dec 21, 1998 | Issued |
Array
(
[id] => 4353702
[patent_doc_number] => 06200801
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-03-13
[patent_title] => 'Serpin enzyme complex receptor-mediated gene transfer'
[patent_app_type] => 1
[patent_app_number] => 9/217847
[patent_app_country] => US
[patent_app_date] => 1998-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 43
[patent_no_of_words] => 44205
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/200/06200801.pdf
[firstpage_image] =>[orig_patent_app_number] => 217847
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/217847 | Serpin enzyme complex receptor-mediated gene transfer | Dec 20, 1998 | Issued |
Array
(
[id] => 6735132
[patent_doc_number] => 20030012767
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-16
[patent_title] => 'VECTORS FOR TISSUE-SPECIFIC REPLICATION'
[patent_app_type] => new
[patent_app_number] => 09/210936
[patent_app_country] => US
[patent_app_date] => 1998-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 12866
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0012/20030012767.pdf
[firstpage_image] =>[orig_patent_app_number] => 09210936
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/210936 | Vectors for tissue-specific replication | Dec 14, 1998 | Issued |
Array
(
[id] => 4282406
[patent_doc_number] => 06267987
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-07-31
[patent_title] => 'Positively charged poly[alpha-(omega-aminoalkyl) glycolic acid] for the delivery of a bioactive agent via tissue and cellular uptake'
[patent_app_type] => 1
[patent_app_number] => 9/210014
[patent_app_country] => US
[patent_app_date] => 1998-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 6016
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/267/06267987.pdf
[firstpage_image] =>[orig_patent_app_number] => 210014
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/210014 | Positively charged poly[alpha-(omega-aminoalkyl) glycolic acid] for the delivery of a bioactive agent via tissue and cellular uptake | Dec 10, 1998 | Issued |
Array
(
[id] => 1290711
[patent_doc_number] => 06630322
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-10-07
[patent_title] => 'Generating replicating molecules in vivo'
[patent_app_type] => B1
[patent_app_number] => 09/194960
[patent_app_country] => US
[patent_app_date] => 1998-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 10
[patent_no_of_words] => 11325
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 145
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/630/06630322.pdf
[firstpage_image] =>[orig_patent_app_number] => 09194960
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/194960 | Generating replicating molecules in vivo | Dec 6, 1998 | Issued |
Array
(
[id] => 1446819
[patent_doc_number] => 06369039
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-04-09
[patent_title] => 'High efficiency local drug delivery'
[patent_app_type] => B1
[patent_app_number] => 09/204254
[patent_app_country] => US
[patent_app_date] => 1998-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 6952
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 100
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/369/06369039.pdf
[firstpage_image] =>[orig_patent_app_number] => 09204254
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/204254 | High efficiency local drug delivery | Dec 2, 1998 | Issued |
Array
(
[id] => 1376632
[patent_doc_number] => 06551586
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-04-22
[patent_title] => 'Malaria vaccine based upon the addition of a MSA1 peptide'
[patent_app_type] => B1
[patent_app_number] => 09/117415
[patent_app_country] => US
[patent_app_date] => 1998-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 21
[patent_no_of_words] => 26701
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/551/06551586.pdf
[firstpage_image] =>[orig_patent_app_number] => 09117415
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/117415 | Malaria vaccine based upon the addition of a MSA1 peptide | Nov 26, 1998 | Issued |
Array
(
[id] => 1139616
[patent_doc_number] => 06776986
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-08-17
[patent_title] => 'Inhibition of HIV-1 replication by antisense RNA expression'
[patent_app_type] => B1
[patent_app_number] => 09/194300
[patent_app_country] => US
[patent_app_date] => 1998-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 8737
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/776/06776986.pdf
[firstpage_image] =>[orig_patent_app_number] => 09194300
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/194300 | Inhibition of HIV-1 replication by antisense RNA expression | Nov 22, 1998 | Issued |
Array
(
[id] => 4375727
[patent_doc_number] => 06261552
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-07-17
[patent_title] => 'Herpes simplex virus vectors'
[patent_app_type] => 1
[patent_app_number] => 9/194274
[patent_app_country] => US
[patent_app_date] => 1998-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 12
[patent_no_of_words] => 9516
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/261/06261552.pdf
[firstpage_image] =>[orig_patent_app_number] => 194274
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/194274 | Herpes simplex virus vectors | Nov 19, 1998 | Issued |
| 09/195367 | VIRAL VECTORS WITH LATE TRANSGENE EXPRESSION | Nov 17, 1998 | Abandoned |
Array
(
[id] => 1311396
[patent_doc_number] => 06610480
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-08-26
[patent_title] => 'Treatment and diagnosis of cardiac hypertrophy'
[patent_app_type] => B1
[patent_app_number] => 09/189618
[patent_app_country] => US
[patent_app_date] => 1998-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 25370
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/610/06610480.pdf
[firstpage_image] =>[orig_patent_app_number] => 09189618
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/189618 | Treatment and diagnosis of cardiac hypertrophy | Nov 8, 1998 | Issued |
Array
(
[id] => 6046827
[patent_doc_number] => 20020168338
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-11-14
[patent_title] => 'COMPOSITIONS AND METHODS FOR DELIVERY OF AGENTS FOR NEURONAL REGENERATION AND SURVIVAL'
[patent_app_type] => new
[patent_app_number] => 09/178286
[patent_app_country] => US
[patent_app_date] => 1998-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 34002
[patent_no_of_claims] => 80
[patent_no_of_ind_claims] => 27
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0168/20020168338.pdf
[firstpage_image] =>[orig_patent_app_number] => 09178286
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/178286 | Compositions and methods for delivery of agents for neuronal regeneration and survival | Oct 22, 1998 | Issued |
| 09/176330 | COMPOSITIONS AND METHODS FOR THE TREATMENT AND DIAGNOSIS OF CADIOVASCULAR DISEASE | Oct 21, 1998 | Abandoned |
Array
(
[id] => 1505974
[patent_doc_number] => 06440419
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-08-27
[patent_title] => 'Epithelial cell targeting agent'
[patent_app_type] => B1
[patent_app_number] => 09/176741
[patent_app_country] => US
[patent_app_date] => 1998-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 31066
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/440/06440419.pdf
[firstpage_image] =>[orig_patent_app_number] => 09176741
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/176741 | Epithelial cell targeting agent | Oct 19, 1998 | Issued |
Array
(
[id] => 4406226
[patent_doc_number] => 06271207
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-08-07
[patent_title] => 'Enhanced expression of transgenes'
[patent_app_type] => 1
[patent_app_number] => 9/175056
[patent_app_country] => US
[patent_app_date] => 1998-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 18560
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/271/06271207.pdf
[firstpage_image] =>[orig_patent_app_number] => 175056
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/175056 | Enhanced expression of transgenes | Oct 18, 1998 | Issued |